Beranda › Kanker Prostat Resisten Kastrasi › North Carolina
Uji klinis Kanker Prostat Resisten Kastrasi di North Carolina
4 studi untuk Kanker Prostat Resisten Kastrasi mencari peserta di lokasi di North Carolina.
Teks studi resmi (Bahasa Inggris)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Duke University Medical Center, Durham
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07225946A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Levine Cancer Institute, Charlotte
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 25 Sep 2026 · NCT07164443A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Duke Cancer Institute, Durham
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 10 Agu 2026 · NCT06067841Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer
- W.G. Bill Hefner VA Medical Center, Salisbury
- Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 13 Apr 2026 · NCT04337580Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.